Real-time enrollment status for this atherosclerosis cardiovascular disease clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 9:25 PM UTC
| NCT Number | NCT07303777 |
| Recruiting Status | Recruiting |
| Condition | Atherosclerosis Cardiovascular Disease |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Atom Therapeutics Co., Ltd |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of July 16, 2026: Clinical trial NCT07303777 is currently recruiting participants. This phase2 study for atherosclerosis cardiovascular disease is actively seeking new participants at 4 locations across the United States. The study is sponsored by Atom Therapeutics Co., Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07303777 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07303777 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.